Sabra Health Care REIT, Inc.
NASDAQ:SBRAREIT - Healthcare Facilities
-$0.11 today
- Market cap
- $5.40B
- Beta
- 0.63
- P/E (TTM)
- 29.0
- EPS (TTM)
- $0.62
- Dividend yield
- 6.69%
Volume 2.42M
Average 2.46M
SBRA Net Margin
Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.
Sabra Health Care REIT, Inc.NASDAQ: SBRA
Net Margin · Q2 FY2026 · quarter ended Jun 2026
Net margin narrows to -10.7%
Net margin was -10.7% in Q2 FY2026, down 45.3 pp from a year earlier. On a trailing-twelve-month basis it was 7.6%, down 17.3 pp year over year. Over 3 fiscal years it widened by 32.5 pp.
Context
- Net margin widened in 3 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
What to watch
Whether net margin reaches the consensus estimate from 4 analysts of 9.1% for the fiscal year ending Dec 2026, down from 20.1% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- -10.7%-29.1 pp QoQ
- Last fiscal yearDec 2025
- 20.1%+2.1 pp YoY
- LTMJun 2026
- 7.6%-17.3 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -45.3 pp | +6.1 pp | +51.4 pp |
| 1 year | +2.1 pp | -11.0 pp | -13.0 pp |
| 3 years | +32.5 pp | -3.8 pp | -36.3 pp |
| 5 years | -20.1 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 20.1%
- Year-over-year change
- +2.1pp
| Period | Period end | Net Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 20.1% | +2.1pp |
| FY2024 | 2024-12-31 | 18.0% | +15.9pp |
| FY2023 | 2023-12-31 | 2.1% | +14.5pp |
| FY2022 | 2022-12-31 | -12.4% | +7.5pp |
| FY2021 | 2021-12-31 | -19.9% | — |
Net Margin vs competitors
How SBRA compares with its peers on the latest reported figures
- SBRA's LTM Jun 2026 net margin of 7.6% is the 6th highest of the 11 companies compared; the peer median is 7.1%.
- Its year-over-year change of -17.3 pp is the 8th highest of 9, against a peer median of +21.9 pp.
- Over three fiscal years its change of +32.5 pp compares with a peer median of +6.8 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Sep 2026 | 152.5% | +111.1 pp | +13.7 pp | |
| LTM Jun 2026 | 66.4% | +24.2 pp | +0.6 pp | |
| LTM Sep 2026 | 59.2% | -21.5 pp | +71.3 pp | |
| LTM Sep 2026 | 18.2% | +19.5 pp | -21.8 pp | |
| LTM Sep 2026 | 10.7% | +0.8 pp | +6.3 pp | |
| LTM Jun 2026 | 7.6% | -17.3 pp | +32.5 pp | |
| LTM Sep 2026 | 3.6% | +2.4 pp | +8.1 pp | |
MPTMedical Properties Trust, Inc. | LTM Jun 2026 | -3.0% | +151.7 pp | -87.0 pp |
| FY2025 | -7.9% | — | — | |
NHPNational Healthcare Properties, Inc. (NHP) | LTM Dec 2025 | -16.8% | — | +6.8 pp |
NHPBPNational Healthcare Properties, Inc. | LTM Mar 2026 | -17.6% | +32.3 pp | +6.8 pp |
| Peer median (excluding SBRA) | 7.1% | +21.9 pp | +6.8 pp | |
Competitors are the stored peer set for SBRA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 569.55M | 624.81M | 647.51M | 703.24M | 774.63M |
| Cost of Revenue | 141.2M | 162.61M | 195.25M | 227.09M | 271.11M |
| Gross Profit | 428.34M | 462.2M | 452.27M | 476.15M | 503.53M |
| Gross Margin | 75.2% | 74.0% | 69.8% | 67.7% | 65.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 34.67M | 39.57M | 47.47M | 50.07M | 53.71M |
| Operating Expenses | 217.6M | 227.36M | 230.56M | 219.12M | 239.66M |
| Depreciation & Amortization | 178.99M | 187.78M | 183.09M | 169.62M | 187M |
| EBITDA | 166.21M | 216.89M | 311.81M | 412.61M | 456.83M |
| EBITDA Margin | 29.2% | 34.7% | 48.2% | 58.7% | 59.0% |
| Operating Income | 210.75M | 234.84M | 221.71M | 257.03M | 263.87M |
| Operating Margin | 37.0% | 37.6% | 34.2% | 36.5% | 34.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 98.63M | 105.47M | 112.96M | 115.27M | 112.49M |
| Other Income / Expenses | (322.16M) | (311.21M) | (205.95M) | (129.31M) | (106.52M) |
| Income Before Tax | (111.41M) | (76.36M) | 15.76M | 127.72M | 157.35M |
| Pre-Tax Margin | -19.6% | -12.2% | 2.4% | 18.2% | 20.3% |
| Income Tax Expense | 1.85M | 1.24M | 2M | 1.01M | 1.84M |
| Net Income | (113.26M) | (77.61M) | 13.76M | 126.71M | 155.61M |
| Net Margin | -19.9% | -12.4% | 2.1% | 18.0% | 20.1% |
| EPS (Basic) | (0.52) | (0.34) | 0.06 | 0.54 | 0.64 |
| EPS (Diluted) | (0.52) | (0.34) | 0.06 | 0.54 | 0.64 |
| Weighted Avg Shares | 219.07M | 230.95M | 231.2M | 233.5M | 241.31M |
| Weighted Avg Shares (Diluted) | 219.07M | 230.95M | 232.79M | 236.05M | 244.5M |
Sabra Health Care REIT, Inc.
NASDAQ:SBRA
Intrinsic Alpha fair value
Locked
Current Price
$20.62
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.